Clinical Trial Update: Magnesium Sulfate in Thrombotic Thrombocytopenic Purpura in Intensive Care [Phase 3]

View source ↗

Summary

Phase 3 trial update investigating magnesium sulfate for thrombotic thrombocytopenic purpura in intensive care.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Thrombotic Thrombocytopenic Purpura

Drugs mentioned

• Magnesium sulfate (magnesium sulfate)

Snippet

Sponsor: Assistance Publique - Hôpitaux de Paris | Conditions: Thrombotic Thrombocytopenic Purpura | Phase 3 | Status: UNKNOWN